rationale of omniverse: oral azacitidine venetoclax in patients with r/r or newly diagnosed aml
Published 2 years ago • 144 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:24
omniverse: safety and tolerability of oral azacitidine plus venetoclax in patients with aml
-
1:33
phase i trial results for oral azacitidine and venetoclax in r/r aml
-
1:12
phase i study of ziftomenib with venetoclax or venetoclax/azacitidine or 7 3 in r/r aml
-
1:50
the challenge of treating elderly patients with aml with venetoclax plus azacitidine
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:23
azacitidine and venetoclax /- gemtuzumab ozogamicin in pediatric patients with r/r acute leukemias
-
2:02
oral azacitidine maintenance in aml with mds-related changes: insights from quazar aml-001
-
7:50
which aml patients benefit most from venetoclax treatment?
-
3:24
pre-induction azacitidine and venetoclax to improve the bone marrow microenvironment in aml
-
3:33
venetoclax (bcl 2 inhibitor)
-
1:08
the importance of predicting venetoclax response in patients with aml
-
3:52
venetoclax & aml
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
2:37
maintenance venetoclax and 5-azacytidine in patients with aml
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
2:11
cpx-351 plus venetoclax in patients with newly-diagnosed high-risk aml
-
1:45
ham-ven as salvage treatment for r/r aml: results from the sal-relax trial
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:51
the safety and efficacy of retreatment with venetoclax plus rituximab in r/r cll